GlassScriptPhysician profile
Travis W Roberts
NPI 1316457534
$1,690.58
in general payments reported to CMS, 2019-2025
10 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.93 · 2022: $223 · 2023: $646 · 2024: $344 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $924.13 | 2021-2025 | |
| Indivior INC. | $294.98 | 2021-2025 | Sublocade |
| Abiomed | $123.40 | 2024 | Impella |
| Glaxosmithkline, LLC. | $111.45 | 2023 | Jesduvroq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $91.37 | 2021-2023 | |
| Neurocrine Biosciences, INC. | $39.44 | 2023-2024 | Ingrezza |
| Alkermes, INC. | $36.98 | 2023 | Lybalvi, Vivitrol |
| Cardiva Medical, INC. | $36.04 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Braeburn INC. | $17.74 | 2024 | Brixadi |
| Noven Therapeutics, LLC | $15.05 | 2024 | Xelstrym, Secuado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.